Toll-like receptor 2 does not contribute to host response during postinfluenza pneumococcal pneumonia

Mark C Dessing1, Koenraad F van der Sluijs, Sandrine Florquin

  • 1Center for Infection and Immunity Amsterdam (CINIMA), Laboratory of Experimental Immunology, Department of Pulmonology, University of Amsterdam, The Netherlands. m.c.dessing@amc.uva.nl

Insights

Toll-like receptor 2 (TLR2) does not impact host defense against secondary Streptococcus pneumoniae pneumonia following influenza A infection in mice. This suggests TLR2 is not a critical mediator in this complex respiratory infection model.

Area of Science:

  • Immunology
  • Microbiology
  • Pulmonology

Background:

  • Influenza A infections can lead to secondary bacterial pneumonia, often caused by Streptococcus pneumoniae.
  • Uncontrolled pulmonary inflammation is a hallmark of severe post-influenza pneumonia.
  • Toll-like receptor 2 (TLR2) is implicated as a potential mediator of exaggerated lung inflammation due to its role in sensing gram-positive bacteria and its upregulation during influenza.

Purpose of the Study:

  • To investigate the role of TLR2 in the host immune response to secondary bacterial pneumonia after influenza A infection.
  • To determine if TLR2 deficiency affects bacterial clearance, lung inflammation, or cytokine profiles in a murine model of post-influenza pneumococcal pneumonia.

Main Methods:

  • Utilized a murine model involving intranasal inoculation with influenza A virus followed by Streptococcus pneumoniae.
  • Employed TLR2 knockout (KO) and wild-type (WT) mice to compare host responses.
  • Assessed bacterial load, lung inflammation markers, and cytokine/chemokine concentrations.

Main Results:

  • Both TLR2 KO and WT mice experienced similar transient weight loss during influenza A infection and fully recovered by day 14.
  • No significant differences were observed between TLR2 KO and WT mice in bacterial growth, overall lung inflammation, or most cytokine/chemokine levels during the secondary pneumococcal pneumonia phase.
  • A minor reduction in pulmonary cytokine-induced neutrophil chemoattractant was noted in TLR2 KO mice.

Conclusions:

  • Toll-like receptor 2 does not play a significant role in host defense against Streptococcus pneumoniae pneumonia complicating influenza A infection in mice.
  • The findings suggest that TLR2 is not a critical therapeutic target for mitigating inflammation in this specific post-influenza bacterial pneumonia model.